Comments on "Tuberculosis infection control in MDR-TB designated hospitals in Jiangsu Province, China". [PDF]
Katkuri SN +4 more
europepmc +1 more source
The Epidemiology of MDR-TB in Peru [PDF]
openaire +1 more source
Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment. [PDF]
Hongler J +10 more
europepmc +1 more source
Influence of Diabetes Mellitus on the Development of Multidrug-Resistant Tuberculosis (MDR-TB) in Relation With Genetic Mutations of <i>M. tuberculosis</i> Isolates in Ethiopia. [PDF]
Seid A, Nureddin S.
europepmc +1 more source
Multidrug-resistant tuberculosis (MDR-TB): an evolving threat to the Nigerian health system - a review. [PDF]
Shehu A +19 more
europepmc +1 more source
Multidrug-resistant tuberculosis (MDR-TB) in people living with HIV: Clinical issues, therapeutic challenges and perspectives in sub-Saharan Africa. A narrative review. [PDF]
Tague C.
europepmc +1 more source
Interim Effectiveness and Safety of Prolonged Bedaquiline Use in Comparison to Standard 24-Week Treatment for MDR-TB: A Multicenter Cohort Study in China. [PDF]
Hu X +8 more
europepmc +1 more source
Genotypic and Phenotypic Methods in the Detection of MDR-TB and Evolution to XDR-TB. [PDF]
Zaporojan N +5 more
europepmc +1 more source
Diagnostic assistance method for RR-TB/MDR-TB patients under treatment based on CNN-LSTM. [PDF]
Li J +9 more
europepmc +1 more source
The critical link between TB infection control process and clinical impact: need for efficacy data and MDR-TB specificity. [PDF]
Aphale P, Dokania S, Shekhar H.
europepmc +1 more source

